July 24, 2013 | Inside Counsel
Regulatory: Avoiding an FCPA or anti-bribery charge after uncovering corruptionLast month, Medtronic Inc. announced that the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) would be closing their Foreign Corrupt Practices Act (FCPA) investigations of the medical device-maker without pursuing any charges or an enforcement action.
By Timothy P. Peterson, Robertson Park
5 minute read
May 29, 2013 | Inside Counsel
Regulatory: Deciding whether to voluntarily disclose a potential FCPA violationOne of the most difficult and consequential decisions a company faces when presented with a corruption allegation is the decision whether or not to self-report to the government.
By Timothy P. Peterson, Robertson Park
5 minute read
Trending Stories